These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9215824)

  • 1. Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
    Xiao H; Mazumdar M; Bajorin DF; Sarosdy M; Vlamis V; Spicer J; Ferrara J; Bosl GJ; Motzer RJ
    J Clin Oncol; 1997 Jul; 15(7):2553-8. PubMed ID: 9215824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
    McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
    J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
    Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
    Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
    J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
    Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
    Saxman SB; Finch D; Gonin R; Einhorn LH
    J Clin Oncol; 1998 Feb; 16(2):702-6. PubMed ID: 9469360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
    Buckner JC; Peethambaram PP; Smithson WA; Groover RV; Schomberg PJ; Kimmel DW; Raffel C; O'Fallon JR; Neglia J; Shaw EG
    J Clin Oncol; 1999 Mar; 17(3):933-40. PubMed ID: 10071287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel in salvage therapy for germ cell tumors.
    Motzer RJ
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
    Motzer RJ; Mazumdar M; Bosl GJ; Bajorin DF; Amsterdam A; Vlamis V
    J Clin Oncol; 1996 Apr; 14(4):1098-105. PubMed ID: 8648363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-etoposide and carboplatin-etoposide induction chemotherapy for good-risk patients with germ cell tumors.
    Tjulandin SA; Garin AM; Mescheryakov AA; Perevodchikova NI; Gorbunova VA; Sokolov AV; Ljubimova NV; Mironova GT; Molchanov GV; Ozols RF
    Ann Oncol; 1993 Sep; 4(8):663-7. PubMed ID: 8240996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
    Loehrer PJ; Gonin R; Nichols CR; Weathers T; Einhorn LH
    J Clin Oncol; 1998 Jul; 16(7):2500-4. PubMed ID: 9667270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of metastatic germ cell tumors with etoposide and cisplatin as first line chemotherapy].
    Shintaku I; Numahata K; Suzuki K; Ohyama C; Sato M; Saito S; Hoshi S; Orikasa S
    Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):519-24. PubMed ID: 12056035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.